Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Nov 2010 for Valeant Pharmaceuticals International, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Margaret Jean Mulligan: trading record in brief
Margaret Jean Mulligan discloses dealings in Valeant Pharmaceuticals International, Inc. to SEDI. Altogether 2 filings, all relating to 8 November 2010.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 10 November 2010: an option exercise, in Valeant Pharmaceuticals International, Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Companies and markets linked to Margaret Jean Mulligan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
102,658 shares0Common Shares, no par valueSEC:0001477126-10-000005:0
47,644 shares@ US$26.12Common Shares, no par valueSEC:0001477126-10-000005:1
2 of 2 declarations
